about
Management of ischaemic stroke in the acute setting: review of the current status.Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems.In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy.A review on composite liposomal technologies for specialized drug delivery.A Co-blended Locust Bean Gum and Polymethacrylate-NaCMC Matrix to Achieve Zero-Order Release via Hydro-Erosive ModulationNovel high-viscosity polyacrylamidated chitosan for neural tissue engineering: fabrication of anisotropic neurodurable scaffold via molecular disposition of persulfate-mediated polymer slicing and complexation.The frequency and profile of neurology in black South African HIV infected (clade C) patients - a hospital-based prospective audit.Burden of stroke in black populations in sub-Saharan Africa.Acute ischaemic stroke: highlighting the need for early intervention.Is stroke a HIV-related neurologic manifestation?Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersNanotechnological applications for the treatment of neurodegenerative disorders.Levodopa delivery systems: advancements in delivery of the gold standard.Advances in the treatment of neurodegenerative disorders employing nanotechnology.Self-assembling peptides: implications for patenting in drug delivery and tissue engineering.A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications.Patient-controlled analgesia: therapeutic interventions using transdermal electro-activated and electro-modulated drug delivery.Nanoparticulate strategies for the five R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization.Current advances in the fabrication of microneedles for transdermal delivery.A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.Multifunctional therapeutic delivery strategies for effective neuro-regeneration following traumatic spinal cord injury.A Hybrid Methacrylate-Sodium Carboxymethylcellulose Interpolyelectrolyte Complex: Rheometry and in Silico Disposition for Controlled Drug Release.Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery.Improving drug delivery technology for treating neurodegenerative diseases.Functionalized Nanolipobubbles Embedded Within a Nanocomposite Hydrogel: a Molecular Bio-imaging and Biomechanical Analysis of the System.AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain.Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders.In Vitro and In Vivo Evaluation of a Hydrogel-Based Microneedle Device for Transdermal Electro-Modulated Analgesia.Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC).Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease.An interfacially plasticized electro-responsive hydrogel for transdermal electro-activated and modulated (TEAM) drug delivery.Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.Accuracy of the Siriraj and Guy's Hospital Stroke Scores in urban South Africans.Differences in the nature of stroke in a multiethnic urban South African population: the Johannesburg hospital stroke register.CIDP in a HIV endemic population: A prospective case series from Johannesburg, South Africa.Composite polylactic-methacrylic Acid copolymer nanoparticles for the delivery of methotrexate.Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.New onset seizures in HIV-infected patients without intracranial mass lesions or meningitis--a clinical, radiological and SPECT scan study.Multiple sclerosis in South Africa.
P50
Q30431467-B081B4F2-27FA-46DF-99B0-7D8E5510E303Q33654487-D83D7CCF-5CE3-48FF-B195-B1E3C146C336Q33826249-86ED9B65-4BFF-44E6-B866-254AEC49DB9DQ34730109-970091F7-17AD-42FF-B8BC-456E3F57F5DFQ36337349-9291B26C-55E3-4AA5-AA10-E9B0B8946679Q36432409-4F57C794-2896-4C6F-AB26-41299EACFEDAQ36732764-199F6E00-108F-4EE7-BDE9-D2CCAC55BB13Q36736805-AFB8A5D7-0CC5-4093-8E39-5F22EE1624C5Q37040992-27675A03-C15E-479E-AB15-6CD1DA1D9297Q37232030-04B3DCF5-1B65-4AE1-BEF5-C6D57E8BD19FQ37249765-A9AAB24E-FC2C-48AC-91FB-4982BF9DAD5FQ37504055-643D2C6B-CDCF-4361-9612-6F58704F0F62Q37679951-53E10736-E7F4-4D5F-9698-ACD7A1C3B5F2Q37690357-B1897F95-C4ED-42EC-B06B-4057320CB1EAQ37818394-5DBE7A96-C573-459E-9115-2A32A6A43933Q38121509-16939872-B0E5-48B3-811E-FB762D6D88ADQ38174512-7526AFB9-8F86-4D3C-8E36-BD080D7F16A1Q38189492-15DE3ABD-05CE-470E-8E4E-C99E7BF5B529Q38210060-80F2E45A-26E9-4DCC-AB88-9CCB30A34134Q38307396-7B36AAF0-5DF4-4346-89E8-891AB881700AQ38320629-623B9614-CD44-4F54-B340-4A5151D80E0DQ38634206-929D9532-B644-4AD3-8CB9-72B90D6DBD0DQ38661732-AA4F8CA2-82E8-47BF-ADFD-9781C55F9EEDQ38769989-8609395D-1BB6-40E7-888A-A6652560E5A6Q38770324-5677715E-C660-4823-B897-8C62E30731D1Q38799779-DDBD60E2-6F80-4F22-8390-51F0B3746B64Q38857113-9FFAA7C2-578C-4CC3-B045-981F53729FD3Q38923198-388AA866-C00F-42A1-B9E9-90D07C3D2817Q39037439-E2E13EAE-7AFA-4AFA-9C1A-83F0C745A327Q39282636-4D9FF637-C1A2-4DF5-AA83-4C792EAF1352Q39300437-B919AFF7-673D-4C1A-A210-CE05997B4A2FQ39305787-1A74817B-CFB9-4C71-A147-E16060420937Q39348380-E1249577-5BE1-41DF-9D4B-7CB813C56557Q39777009-C1011D28-6CAF-4382-BFC0-94A40F7A1CABQ39866826-CFBAC76D-3DE5-4AA8-95E9-37F0397B740DQ39901129-1AE1244E-BF1A-4655-8625-B6AB5D8C62CDQ42125272-B4017E24-9784-4C9F-9E65-2FD6F728BE58Q43286935-12A1E599-6035-40CF-A877-8214B0D2F158Q44762861-0DCCE2A8-B83D-49F5-884D-509806A53646Q44855732-451E06D2-AA21-4E10-ABBF-A25D35B83FE0
P50
name
Girish Modi
@en
Girish Modi
@nl
type
label
Girish Modi
@en
Girish Modi
@nl
prefLabel
Girish Modi
@en
Girish Modi
@nl